SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-19-000280
Filing Date
2019-10-10
Accepted
2019-10-10 17:06:48
Documents
1
Group Members
ARCH VENTURE FUND X OVERAGE, L.P.ARCH VENTURE PARTNERS VI, L.P.ARCH VENTURE PARTNERS VI, LLCARCH VENTURE PARTNERS X OVERAGE, L.P.ARCH VENTURE PARTNERS X, LLCCLINTON BYBEEKEITH CRANDELLKRISTINA BUROWROBERT NELSENSTEVEN GILLIS

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VI, L.P. - SCHEDULE 13D/A (#1) - VBI VACCINES, INC. vbi13da1_18345.htm SC 13D/A 382933
  Complete submission text file 0001072613-19-000280.txt   385067
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Subject) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89195 | Film No.: 191146617
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631
Business Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631 7733806600
ARCH VENTURE FUND VI LP (Filed by) CIK: 0001222135 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A